Cargando…

Prognostic Factors Associated With Surviving Less Than 3 Months vs Greater Than 3 Years Specific to Spine Stereotactic Body Radiotherapy and Late Adverse Events

Detalles Bibliográficos
Autores principales: Zeng, K Liang, Sahgal, Arjun, Tseng, Chia-Lin, Myrehaug, Sten, Soliman, Hany, Detsky, Jay, Atenafu, Eshetu G, Lee, Young, Campbell, Mikki, Maralani, Pejman, Husain, Zain A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600281/
http://dx.doi.org/10.1093/neuros/nyaa583_S120
_version_ 1784601120259178496
author Zeng, K Liang
Sahgal, Arjun
Tseng, Chia-Lin
Myrehaug, Sten
Soliman, Hany
Detsky, Jay
Atenafu, Eshetu G
Lee, Young
Campbell, Mikki
Maralani, Pejman
Husain, Zain A
author_facet Zeng, K Liang
Sahgal, Arjun
Tseng, Chia-Lin
Myrehaug, Sten
Soliman, Hany
Detsky, Jay
Atenafu, Eshetu G
Lee, Young
Campbell, Mikki
Maralani, Pejman
Husain, Zain A
author_sort Zeng, K Liang
collection PubMed
description
format Online
Article
Text
id pubmed-8600281
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-86002812021-11-18 Prognostic Factors Associated With Surviving Less Than 3 Months vs Greater Than 3 Years Specific to Spine Stereotactic Body Radiotherapy and Late Adverse Events Zeng, K Liang Sahgal, Arjun Tseng, Chia-Lin Myrehaug, Sten Soliman, Hany Detsky, Jay Atenafu, Eshetu G Lee, Young Campbell, Mikki Maralani, Pejman Husain, Zain A Neurosurgery Neurosurgery 20/20: Concise, Clear Content Oxford University Press 2021-11-18 /pmc/articles/PMC8600281/ http://dx.doi.org/10.1093/neuros/nyaa583_S120 Text en © Congress of Neurological Surgeons 2021. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Neurosurgery 20/20: Concise, Clear Content
Zeng, K Liang
Sahgal, Arjun
Tseng, Chia-Lin
Myrehaug, Sten
Soliman, Hany
Detsky, Jay
Atenafu, Eshetu G
Lee, Young
Campbell, Mikki
Maralani, Pejman
Husain, Zain A
Prognostic Factors Associated With Surviving Less Than 3 Months vs Greater Than 3 Years Specific to Spine Stereotactic Body Radiotherapy and Late Adverse Events
title Prognostic Factors Associated With Surviving Less Than 3 Months vs Greater Than 3 Years Specific to Spine Stereotactic Body Radiotherapy and Late Adverse Events
title_full Prognostic Factors Associated With Surviving Less Than 3 Months vs Greater Than 3 Years Specific to Spine Stereotactic Body Radiotherapy and Late Adverse Events
title_fullStr Prognostic Factors Associated With Surviving Less Than 3 Months vs Greater Than 3 Years Specific to Spine Stereotactic Body Radiotherapy and Late Adverse Events
title_full_unstemmed Prognostic Factors Associated With Surviving Less Than 3 Months vs Greater Than 3 Years Specific to Spine Stereotactic Body Radiotherapy and Late Adverse Events
title_short Prognostic Factors Associated With Surviving Less Than 3 Months vs Greater Than 3 Years Specific to Spine Stereotactic Body Radiotherapy and Late Adverse Events
title_sort prognostic factors associated with surviving less than 3 months vs greater than 3 years specific to spine stereotactic body radiotherapy and late adverse events
topic Neurosurgery 20/20: Concise, Clear Content
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600281/
http://dx.doi.org/10.1093/neuros/nyaa583_S120
work_keys_str_mv AT zengkliang prognosticfactorsassociatedwithsurvivinglessthan3monthsvsgreaterthan3yearsspecifictospinestereotacticbodyradiotherapyandlateadverseevents
AT sahgalarjun prognosticfactorsassociatedwithsurvivinglessthan3monthsvsgreaterthan3yearsspecifictospinestereotacticbodyradiotherapyandlateadverseevents
AT tsengchialin prognosticfactorsassociatedwithsurvivinglessthan3monthsvsgreaterthan3yearsspecifictospinestereotacticbodyradiotherapyandlateadverseevents
AT myrehaugsten prognosticfactorsassociatedwithsurvivinglessthan3monthsvsgreaterthan3yearsspecifictospinestereotacticbodyradiotherapyandlateadverseevents
AT solimanhany prognosticfactorsassociatedwithsurvivinglessthan3monthsvsgreaterthan3yearsspecifictospinestereotacticbodyradiotherapyandlateadverseevents
AT detskyjay prognosticfactorsassociatedwithsurvivinglessthan3monthsvsgreaterthan3yearsspecifictospinestereotacticbodyradiotherapyandlateadverseevents
AT atenafueshetug prognosticfactorsassociatedwithsurvivinglessthan3monthsvsgreaterthan3yearsspecifictospinestereotacticbodyradiotherapyandlateadverseevents
AT leeyoung prognosticfactorsassociatedwithsurvivinglessthan3monthsvsgreaterthan3yearsspecifictospinestereotacticbodyradiotherapyandlateadverseevents
AT campbellmikki prognosticfactorsassociatedwithsurvivinglessthan3monthsvsgreaterthan3yearsspecifictospinestereotacticbodyradiotherapyandlateadverseevents
AT maralanipejman prognosticfactorsassociatedwithsurvivinglessthan3monthsvsgreaterthan3yearsspecifictospinestereotacticbodyradiotherapyandlateadverseevents
AT husainzaina prognosticfactorsassociatedwithsurvivinglessthan3monthsvsgreaterthan3yearsspecifictospinestereotacticbodyradiotherapyandlateadverseevents